Inhibition of Laser Induced Rats Choroidal Neovascularization by Intravitreous Injection of SEphB4-HSA

Overview

Journal Ann Transl Med

Publisher AME Publishing Company

Date 2021 Feb 8

PMID 33553311

Citations 2

Authors

Shikun He

Sha Ouyang

Xiaohua Li

Binyun Ma

Affiliations

Soon will be listed here.

Abstract

Background: Choroidal neovascularization (CNV) is a leading cause of central vision loss complicated with age-related macular degeneration. Although intravitreal anti-VEGF therapy is widely used in wet age-related macular degeneration, optimal treatment regimens for the disease are still under investigation. EphrinB2 and EphB4 regulate angiogenesis, and interruption of EphB4/ephrinB2 has been demonstrated to inhibit angiogenesis. In the current study, we studied the effects of soluble EphB4 (sEphB4) on laser induced CNV in a rat model by intravitreous injection and the underlying mechanism.

Methods: Male rats (Brown-Norway) were used in the study. CNV was induced by laser and the sEphB4 was injected intravitreous after laser at days 3 and 7. The CNV lesions were evaluated by three methods: fluorescein angiography (FA) , CNV volume by confocal analysis of choroidal flat-mounts and H&E staining. The expression of fibronectin (FN), VEGFR-2, phospho-VEGFR-2 (pVEGFR-2), the double labeling of EphB4 with FN was analyzed by immunofluorescence. The interaction of FN with EphB4 and the effects of intraocular injection of sEphB4 on the inhibition of pVEGFR-2 were determined by western blot.

Results: The FA leakage and CNV volume were significantly inhibited by the injection of the sEphB4. Further, histology analysis showed that CNV lesion was significantly smaller in the rats with sEphB4 injection than rats with placebo application. The expressions of pVEGFR-2 and FN in the CNV lesions were reduced compared with controls.

Conclusions: Our study suggests that the inhibition of CNV by sEphB4 may be through suppression of VEGFR-2 phosphorylation and the expression of FN. sEphB4 may be a new potential therapeutic strategy of CNV.

Citing Articles

Erratum to inhibition of laser induced rats choroidal neovascularization by intravitreous injection of sEphB4-HSA.

Ann Transl Med. 2022; 10(17):947.

PMID: 36172096 PMC: 9511186. DOI: 10.21037/atm-2022-19.

Eph Receptors and Ephrins in Retinal Diseases.

Kaczmarek R, Gajdzis P, Gajdzis M Int J Mol Sci. 2021; 22(12).

PMID: 34201393 PMC: 8227845. DOI: 10.3390/ijms22126207.

References

Day S, Acquah K, Mruthyunjaya P, Grossman D, Lee P, Sloan F . Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. Am J Ophthalmol. 2011; 152(2):266-72. PMC: 3143287. DOI: 10.1016/j.ajo.2011.01.053. View

Brar M, Cheng L, Yuson R, Mojana F, Freeman W, Gill P . Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4/EphrinB2 signalling. Br J Ophthalmol. 2010; 94(12):1668-73. DOI: 10.1136/bjo.2010.182881. View

Kwak N, Okamoto N, Wood J, Campochiaro P . VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2000; 41(10):3158-64. View

Li X, Choi W, Yan R, Yu H, Krasnoperov V, Kumar S . The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. PLoS One. 2014; 9(8):e105326. PMC: 4141800. DOI: 10.1371/journal.pone.0105326. View

Ozaki E, Campbell M, Kiang A, Humphries M, Doyle S, Humphries P . Inflammation in age-related macular degeneration. Adv Exp Med Biol. 2014; 801:229-35. DOI: 10.1007/978-1-4614-3209-8_30. View

Liu Z, Fan F, Wang A, Zheng S, Lu Y . Dll4-Notch signaling in regulation of tumor angiogenesis. J Cancer Res Clin Oncol. 2013; 140(4):525-36. DOI: 10.1007/s00432-013-1534-x. View

Davis G, Senger D . Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res. 2005; 97(11):1093-107. DOI: 10.1161/01.RES.0000191547.64391.e3. View

Barrientos S, Stojadinovic O, Golinko M, Brem H, Tomic-Canic M . Growth factors and cytokines in wound healing. Wound Repair Regen. 2009; 16(5):585-601. DOI: 10.1111/j.1524-475X.2008.00410.x. View

Grossniklaus H, Green W . Choroidal neovascularization. Am J Ophthalmol. 2004; 137(3):496-503. DOI: 10.1016/j.ajo.2003.09.042. View

10.

Pasquale E . Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol. 2005; 6(6):462-75. DOI: 10.1038/nrm1662. View

11.

Abengozar M, de Frutos S, Ferreiro S, Soriano J, Perez-Martinez M, Olmeda D . Blocking ephrinB2 with highly specific antibodies inhibits angiogenesis, lymphangiogenesis, and tumor growth. Blood. 2012; 119(19):4565-76. DOI: 10.1182/blood-2011-09-380006. View

12.

Umeda N, Ozaki H, Hayashi H, Oshima K . Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases. Am J Ophthalmol. 2004; 138(2):270-9. DOI: 10.1016/j.ajo.2004.04.006. View

13.

Nalluri S, Chu D, Keresztes R, Zhu X, Wu S . Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA. 2008; 300(19):2277-85. DOI: 10.1001/jama.2008.656. View

14.

Grisanti S, Zhu Q, Tatar O, Lueke J, Lueke M, Tura A . Differential expression of vascular endothelial growth factor-a isoforms in neovascular age-related macular degeneration. Retina. 2014; 35(4):764-72. DOI: 10.1097/IAE.0000000000000385. View

15.

Courtoy P, Boyles J . Fibronectin in the microvasculature: localization in the pericyte-endothelial interstitium. J Ultrastruct Res. 1983; 83(3):258-73. DOI: 10.1016/s0022-5320(83)90133-8. View

16.

Gu L, Chen H, Tuo J, Gao X, Chen L . Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA. Exp Eye Res. 2010; 91(3):433-9. DOI: 10.1016/j.exer.2010.06.019. View

17.

Hielscher A, Ellis K, Qiu C, Porterfield J, Gerecht S . Fibronectin Deposition Participates in Extracellular Matrix Assembly and Vascular Morphogenesis. PLoS One. 2016; 11(1):e0147600. PMC: 4728102. DOI: 10.1371/journal.pone.0147600. View

18.

Du E, Li X, He S, Li X, He S . The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis. Mol Biol Rep. 2020; 47(6):4681-4690. DOI: 10.1007/s11033-020-05470-y. View

19.

Uhl C, Markel M, Broggini T, Nieminen M, Kremenetskaia I, Vajkoczy P . EphB4 mediates resistance to antiangiogenic therapy in experimental glioma. Angiogenesis. 2018; 21(4):873-881. PMC: 6208883. DOI: 10.1007/s10456-018-9633-6. View

20.

Hollanders K, Van Bergen T, Van de Velde S, Sijnave D, Vandewalle E, Moons L . Bevacizumab revisited: its use in different mouse models of ocular pathologies. Curr Eye Res. 2014; 40(6):611-21. DOI: 10.3109/02713683.2014.943910. View